BGMS

MKT CAP:$2M

Bio Green Med Solution, Inc.

Market Cap

$2M

Healthcare·Medical - Pharmaceuticals·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$0.97-$0.44 (-31.21%)

Apr 24, 2026

Company Details

A diversified company operating in both the fire protection and biopharmaceutical industries. It expanded its portfolio by acquiring Fitters Sdn. Bhd., a Malaysian fire protection products and services group. Focuses on advancing opportunit...

CEO

Sing Ee Wong

IPO Date

Sep 12, 2025

Website

www.bgmsglobal.com

Key Metrics TTM

Revenue

$747.0K

+1637.2% YoY

Net Income

-$3M

EPS (Diluted)

-$4.45

Free Cash Flow

-$5M

Revenue / Share

$0.16

Gross Margin

18.3%

Operating Margin

-1128.1%

Net Margin

-401.3%

FCF Margin

-638.6%

P/S

2.8x

P/E

—

Earnings Reports

Q1 2026

May 13, 2026

PENDING

FY 2025

Dec 31, 2025

$747.0K+1637.2%EPS -$6.45

Q4 2025

Dec 31, 2025

$666.0KEPS -$2.21

Q3 2025

Sep 30, 2025

$81.0K+710.0%EPS -$1.31

Q2 2025

Jun 30, 2025

$0-100.0%EPS -$0.84

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$0	-$5M	-$5M
Q2 22	$0	-$8.0K	-$4M
Q3 22	$0	-$7.0K	-$5M
Q4 22	$0	$5M	-$9M
Q1 23	$0	-$8.0K	-$7M
Q2 23	$373.0K	$373.0K	-$6M
Q3 23	$16.0K	$16.0K	-$6M
Q4 23	$31.0K	$23.0K	-$6M
Q1 24	$29.0K	$27.0K	-$7M
Q2 24	$4.0K	$4.0K	-$4M
Q3 24	$10.0K	$10.0K	-$2M
Q4 24	$0	-$1.0K	-$2M
Q1 25	$0	$0	-$5M
Q2 25	$0	-$1.0K	-$1M
Q3 25	$81.0K	$17.0K	-$992.0K
Q4 25	$666.0K	$121.0K	-$1M

Valuation

Quarter	P/S	P/E
Q1 22	—	—
Q2 22	—	—
Q3 22	—	—
Q4 22	—	—
Q1 23	—	—
Q2 23	10.6x	—
Q3 23	10.2x	—
Q4 23	9.4x	—
Q1 24	8.8x	—
Q2 24	49.4x	—
Q3 24	53.5x	—
Q4 24	92.0x	—
Q1 25	282.6x	—
Q2 25	395.6x	—
Q3 25	45.5x	—
Q4 25	1.5x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$7M	-$7M
Q2 22	-$2M	-$2M
Q3 22	-$7M	-$7M
Q4 22	-$5M	-$5M
Q1 23	-$7M	-$7M
Q2 23	-$1M	-$1M
Q3 23	-$4M	-$4M
Q4 23	-$4M	-$4M
Q1 24	-$483.0K	-$483.0K
Q2 24	-$3M	-$3M
Q3 24	-$3M	-$3M
Q4 24	-$1M	-$1M
Q1 25	-$3M	-$3M
Q2 25	-$1M	-$1M
Q3 25	-$434.0K	-$434.0K
Q4 25	-$33.0K	-$33.0K

Capital Expenditures

Quarter	CapEx
Q1 22	$4.0K
Q2 22	$3.0K
Q3 22	$0
Q4 22	$0
Q1 23	$6.0K
Q2 23	$0
Q3 23	$0
Q4 23	$0
Q1 24	$0
Q2 24	$0
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0
Q4 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	—	+15.2%
Q2 22	—	-31.4%
Q3 22	—	-18.9%
Q4 22	—	+47.8%
Q1 23	—	+39.5%
Q2 23	—	+41.0%
Q3 23	—	+32.8%
Q4 23	—	-34.5%
Q1 24	—	+5.6%
Q2 24	-98.9%	-38.2%
Q3 24	-37.5%	-66.2%
Q4 24	-100.0%	-68.4%
Q1 25	-100.0%	-31.1%
Q2 25	-100.0%	-63.9%
Q3 25	+710.0%	-50.9%
Q4 25	—	-4.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$380.0K	—
Q2 22	$350.0K	—
Q3 22	$389.0K	—
Q4 22	$386.0K	—
Q1 23	$401.0K	—
Q2 23	$359.0K	96.2%
Q3 23	$390.0K	2437.5%
Q4 23	$322.0K	1038.7%
Q1 24	$203.0K	700.0%
Q2 24	$189.0K	4725.0%
Q3 24	$107.0K	1070.0%
Q4 24	$93.0K	—
Q1 25	$2M	—
Q2 25	$7.0K	—
Q3 25	$6.0K	7.4%
Q4 25	$655.0K	98.3%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 22	$5M	$2M	$14.7K
Q2 22	$4M	$2M	—
Q3 22	$4M	$2M	—
Q4 22	$7M	$2M	—
Q1 23	$6M	$2M	$17.9K
Q2 23	$5M	$2M	—
Q3 23	$5M	$2M	—
Q4 23	$4M	$2M	—
Q1 24	$6M	$2M	—
Q2 24	$2M	$2M	—
Q3 24	$950.0K	$1M	—
Q4 24	$880.0K	$948.0K	—
Q1 25	$822.0K	$4M	—
Q2 25	$67.0K	$1M	—
Q3 25	$5.0K	$1M	—
Q4 25	—	$1M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$30M	$0	$30M
Q2 22	$29M	$0	$29M
Q3 22	$24M	$0	$24M
Q4 22	$18M	$0	$18M
Q1 23	$11M	$0	$11M
Q2 23	$10M	$0	$10M
Q3 23	$6M	$0	$6M
Q4 23	$3M	$0	$3M
Q1 24	$3M	$0	$3M
Q2 24	$6M	$0	$6M
Q3 24	$3M	$0	$3M
Q4 24	$3M	$0	$3M
Q1 25	$3M	$0	$3M
Q2 25	$4M	$0	$4M
Q3 25	$4M	$0	$4M
Q4 25	$4M	$0	$4M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	3K	+1.5%	+40.8%
Q2 22	3K	+1.4%	+9.7%
Q3 22	3K	+21.5%	+31.4%
Q4 22	3K	+1.8%	+27.4%
Q1 23	3K	0.0%	+25.5%
Q2 23	3K	+0.1%	+23.8%
Q3 23	4K	+0.7%	+2.7%
Q4 23	4K	+1.3%	+2.2%
Q1 24	5K	+52.0%	+55.2%
Q2 24	8K	+39.1%	+115.7%
Q3 24	9K	+19.2%	+155.4%
Q4 24	39K	+329.5%	+982.3%
Q1 25	864K	+2143.3%	+15877.5%
Q2 25	2M	+83.4%	+20960.6%
Q3 25	2M	+20.7%	+21228.1%
Q4 25	5M	+140.9%	+11862.7%

Shares Outstanding